Nicole Murphy, Head of Pharm Operations and Technology at BIOGEN INC. (BIIB), bought 3 shares at $195.04 ($585) on 2026-02-12, disclosed to the SEC on 2026-02-17.
Seasonal purchase ($585) by Head of Pharm Operations and Technology — this insider has traded BIIB in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.